Andrea Difabio
Chief Legal Officer · 2 filings · Latest: Mar 12, 2026
Xenon Pharmaceuticals Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
XENE | Andrea Difabio | Chief Legal Officer | Mar 13, 2026 | Sale | $55.23 | 1,342 | $74.1K | 7,301 | |
XENE | Andrea Difabio | Chief Legal Officer | Mar 12, 2026 | Option Exercise | — | 3,750 | — | 8,643 | |
XENE | ANDREA DIFABIO | — | Mar 13, 2026 | Proposed Sale | $55.23 | 1,342 | $74.1K | — | |
XENE | Andrea Difabio | Chief Legal Officer | Mar 10, 2026 | Sale | $60.11 | 2,607 | $156.7K | 4,893 | |
XENE | Andrea Difabio | Chief Legal Officer | Mar 9, 2026 | Option Exercise | — | 7,500 | — | 7,500 | |
XENE | ANDREA DIFABIO | — | Mar 10, 2026 | Proposed Sale | $60.11 | 2,607 | $156.7K | — |